Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT)

International Journal of Radiation Oncology Biology Physics

Volumn 62, Issue 4, 2005, Pages 1040-1047

  Vu Nishino, Ha ^a   Tavassoli, Fattaneh A ^a   Ahrens, Willam A ^a   Haffty, Bruce G ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

BRCA1 2; Breast cancer; conservative surgery; Medullary breast carcinoma; radiation

Indexed keywords

DIAGNOSIS; HISTOLOGY; MUTAGENESIS; PATHOLOGY; PATIENT TREATMENT; RADIOLOGY; RADIOTHERAPY; SCREENING; TUMORS;

BREAST CANCER; BREAST-CONSERVING THERAPY (BCT); MEDULLARY CARCINOMA; MUTATIONS;

ONCOLOGY;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE MUTATION; HISTOLOGY; HUMAN; MEDICAL RECORD; MEDULLARY CARCINOMA; PARTIAL MASTECTOMY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, MEDULLARY; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MIDDLE AGED; MUTATION; PROGNOSIS; TREATMENT OUTCOME;

EID: 21244462227     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.01.008     Document Type: Article

References (46)

1. R. Cotran Robbins pathologic basis of disease 6th ed 1999 WB Saunders Philadelphia p. 1111
2. O. Moore, F. Foote The relatively favorable prognosis of medullary carcinomas of the breast Cancer 2 1949 635 642
3. R.L. Ridolfi, P.P. Rosen, A. Port Medullary carcinoma of the breast A clinicopathologic study with 10 year follow-up Cancer 40 1977 1365 1385
4. H. Bloom, W. Richardson, J. Field Host resistance and survival in carcinoma of breast A study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years Br Med J 3 1970 181 188
5. S. Shousha Medullary carcinoma of the breast and BRCA1 mutation Histopathology 37 2000 182 185
6. T. Tot The cytokeratin profile of medullary carcinoma of the breast Histopathology 37 2000 175 181
7. M. Kajiwara, S. Toyoshima, T. Yao Apoptosis and cell proliferation in medullary carcinoma of the breast A comparative study between medullary and non-medullary carcinoma using the TUNEL method and immunohistochemistry J Surg Oncol 70 1999 209 216
8. L. Pedersen, S. Holck, T. Schiodt Medullary carcinoma of the breast, prognostic importance of characteristic histopathological features evaluated in a multivariate Cox analysis Eur J Cancer 30A 1994 1792 1797
9. L. Pedersen, K. Zedeler, S. Holck Medullary carcinoma of the breast Prevalence and prognostic importance of classical risk factors in breast cancer Eur J Cancer 31A 1995 2289 2295
10. E. Yakirevich, L. Maroun, O. Cohen Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast J Pathol 192 2000 166 173
11. B.G. Haffty, D. Fischer, J.J. Fischer Regional nodal irradiation in the conservative treatment of breast cancer Int J Radiat Oncol Biol Phys 19 1990 859 865
12. R. Ridolfi, P. Rosen Medullary carcinoma of the breast A clinical and pathological study with 10 year follow-up Cancer 40 1977 1365 1385
13. M. Gaffey, S. Mills, H. Frierson Medullary carcinoma of the breast Interobserver variability in histopathologic diagnosis Mod Pathol 8 1995 31 38
14. F. Tavassoli, M. Devilee World Health Organization classification tumours of the breast and female genital organs pathology and genetics 2003 World Health Organization Lyon, France
15. V. Rapin, G. Contesso, H. Mouriesse Medullary breast carcinoma A reevaluation of 95 cases of breast cancer with inflammatory stroma Cancer 61 1988 2503 2510
16. E.S. Wargotz, S.G. Silverberg Medullary carcinoma of the breast A clinicopathologic study with appraisal of current diagnostic criteria Hum Pathol 19 1988 1340 1346
17. M.L. Jensen, H. Kiaer, J. Andersen Prognostic comparison of three classifications for medullary carcinomas of the breast Histopathology 30 1997 523 532
18. M. Reinfuss, A. Stelmach, J. Mitus Typical medullary carcinoma of the breast A clinical and pathological analysis of 52 cases J Surg Oncol 60 1995 89 94
19. C. Rigaud, S. Theobald, P. Noel Medullary carcinoma of the breast A multicenter study of its diagnostic consistency Arch Pathol Lab Med 117 1993 1005 1008
20. I.O. Ellis, M. Galea, N. Broughton Pathological prognostic factors in breast cancer. II. Histological type Relationship with survival in a large study with long-term follow-up Histopathology 20 1992 479 489
21. E.R. Fisher, J.P. Kenny, R. Sass Medullary cancer of the breast revisited Breast Cancer Res Treat 16 1990 215 229
22. W.P. Maier, G.P. Rosemond, L.I. Goldman A ten year study of medullary carcinoma of the breast Surg Gynecol Obstet 144 1977 695 698
23. A. Fourquet, J.R. Vilcoq, B. Zafrani Medullary breast carcinoma The role of radiotherapy as primary treatment Radiother Oncol 10 1987 1 6
24. A. Marchetti, F. Buttitta, S. Pellegrini p53 mutations and histological type of invasive breast carcinoma Cancer Res 53 1993 4665 4669
25. D.L. Cook, D.L. Weaver Comparison of DNA content, S-phase fraction, and survival between medullary and ductal carcinoma of the breast Am J Clin Pathol 104 1995 17 22
26. F. Eisinger, J. Jacquemier, C. Charpin Mutations at BRCA1 The medullary breast carcinoma revisited Cancer Res 58 1998 1588 1592
27. F. Eisinger, D. Stoppa-Lyonnet, M. Longy Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer Cancer Res 56 1996 471 474
28. J.N. Marcus, P. Watson, D.L. Page Hereditary breast cancer Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage Cancer 77 1996 697 709
29. J. Jacquemier, F. Eisinger, D. Birnbaum Histoprognostic grade in BRCA1-associated breast cancer Lancet 345 1995 1503
30. Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349 1997 1505 1510
31. L.C. Verhoog, C.T. Brekelmans, C. Seynaeve Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 Lancet 351 1998 316 321
32. Y. Miki, J. Swensen, D. Shattuck-Eidens A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 1994 66 71
33. S. Kim, D. Rimm, D. Carter BRCA status, molecular markers, and clinical variables in early, conservatively managed breast cancer Breast J 9 2003 167 174
34. J.E. Armes, L. Trute, D. White Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers A population-based study Cancer Res 59 1999 2011 2017
35. N. Loman, O. Johannsson, P.O. Bendahl Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes Cancer 83 1998 310 319
36. O.T. Johannsson, I. Idvall, C. Anderson Tumour biological features of BRCA1-induced breast and ovarian cancer Eur J Cancer 33 1997 362 371
37. S.E. Karp, P.N. Tonin, L.R. Begin Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women Cancer 80 1997 435 441
38. D.E. Porter, B.B. Cohen, M.R. Wallace Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21 Br J Surg 81 1994 1512 1515
39. H.T. Lynch, J.N. Marcus, P. Watson Distinctive clinicopathological features of BRCA1 linked herediatary breast cancer (abstr 27) Proc ASCO 13 1994 56
40. J.S. Lee, S. Wacholder, J.P. Struewing Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers J Natl Cancer Inst 91 1999 259 263
41. M. Robson, T. Gilewski, B. Haas BRCA-associated breast cancer in young women J Clin Oncol 16 1998 1642 1649
42. A. de la Rochefordiere, B. Asselain, F. Campana Age as prognostic factor in premenopausal breast carcinoma Lancet 341 1993 1039 1043
43. R. Walker, E. Lees, M. Webb Breast carcinomas occurring in young women (< 35 years) are different Br J Cancer 74 1996 1796 1800
44. C. Gajdos, P.I. Tartter, I.J. Bleiweiss Stage 0 to stage III breast cancer in young women J Am Coll Surg 190 2000 509 515
45. N. Kroman, M.-B. Jensen, J. Wohlfahrt Factors influencing the effect of age on prognosis in breast cancer Population based study Br Med J 320 2000 474
46. P. Bertheau, S.M. Steinberg, K. Cowan Breast cancer in young women Clinicopathologic correlation Semin Diagn Pathol 16 1999 248 256